DH
Definitive Healthcare Corp.
DH lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
DH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Weak |
DH's cash flow is currently stable, but its revenue, profitability and balance sheet are under pressure.
DH PE Valuation
DH has no meaningful PE right now: it lost money over the past year.
DH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect DH's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
DH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.18 | — |
| Q3 2026 | -$1.55 | +$0.14 |
| Q2 2026 | -$1.65 | +$1.02 |
| Q1 2026 | -$1.67 | +$2.74 |
| Q4 2025 | -$1.30 | +$2.24 |
| Q3 2025 | -$1.69 | +$1.42 |
| Q2 2025 | -$2.67 | +$0.82 |
| Q1 2025 | -$4.41 | -$2.65 |
| Q4 2024 | -$3.54 | -$1.75 |
DH is still losing money, but far less than before: $1.55 per share over the past year, against $4.41 at its worst in early 2025.
DH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.7M | -9% |
| Q2 2026 | $55.2M | -9.1% |
| Q1 2026 | $55.9M | -5.5% |
| Q4 2025 | $61.5M | -1.2% |
| Q3 2025 | $60M | -4.2% |
| Q2 2025 | $60.8M | -4.7% |
| Q1 2025 | $59.2M | -6.8% |
| Q4 2024 | $62.3M | -5.5% |
DH's revenue has slid since its 2023 peak: $55M last quarter, down 9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.1% | +5.4 points |
| Q2 2026 | -12% | -5.4 points |
| Q1 2026 | -360% | -48 points |
| Q4 2025 | -43% | +117 points |
| Q3 2025 | -14% | +345 points |
| Q2 2025 | -6.9% | +573 points |
| Q1 2025 | -312% | -287 points |
| Q4 2024 | -160% | -145 points |
DH's operating margin was −9.1% last quarter, up 5.4 points from the same quarter a year ago.
DH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9M | -33% |
| Q2 2026 | $8.5M | +21% |
| Q1 2026 | $8.4M | -54% |
| Q4 2025 | -$1.7M | +$1M |
| Q3 2025 | $13.4M | -28% |
| Q2 2025 | $7M | -49% |
| Q1 2025 | $18.4M | +12% |
| Q4 2024 | -$2.8M | -167% |
DH still generates free cash flow, though less than at its 2024 peak: $24M over the past year.
DH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +957K shares |
| 1 year | +2.9% | +3M shares |
| 3 years | -6.8% | -7.8M shares |
| 5 years | +21% | +18.5M shares |
| Available history | -9.8% | -11.5M shares |
DH has 107M diluted shares, up 2.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $9.2M |
| Q2 2025 | $19.1M |
| Q1 2025 | $21.2M |
| Q4 2024 | $7.3M |
DH hasn't bought back shares in the past year.
DH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 8.5x | High |
| Q1 2021 | 0.5x | Very low |
| Q4 2020 | 8.9x | High |
DH's net debt is about 8.5 years of its operating earnings (EBITDA).
DH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.1 | Neutral |
| Stochastic | 86.0 | Overbought |
DH's weekly RSI is 60 (neutral) and its Stochastic is 86 (overbought).
DH PE vs Healthcare Sector
DH has no meaningful PE right now: it lost money over the past year.
DH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.06 | 18% above |
| 20 week MA | $0.91 | 37% above |
| 50 week MA | $1.26 | 0.8% below |
| 100 week MA | $2.43 | 49% below |
| 200 week MA | $5.21 | 76% below |
DH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 76% below its 200-week average.
DH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $49.0 | $28.4 | -42% |
| 2022 | $28.4 | $11.4 | -60% |
| 2023 | $11.4 | $9.94 | -13% |
| 2024 | $9.94 | $4.23 | -57% |
| 2025 | $4.23 | $2.63 | -38% |
| 2026 YTD | $2.63 | $1.25 | -52% |
DH has finished every year since 2021 lower, and it's down 52% so far in 2026.